Z-H Wu

Identifying LRRC16B as an oncofetal gene with transforming enhancing capability using a combined bioinformatics and experimental approach

N. Chow, H. Tsai, C. Chou, 2011, Oncogene.

MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity

L. Pfeffer, X. Ye, Z. Shao, 2015, Oncogene.

RNAi screening identifies TAK1 as a potential target for the enhanced efficacy of topoisomerase inhibitors.

Y. Pommier, N. Caplen, R. Guha, 2011, Current cancer drug targets.

FERMT1 mediates epithelial–mesenchymal transition to promote colon cancer metastasis via modulation of β-catenin transcriptional activity

Senlin Zhao, Zhi-Hai Peng, Zehua Wu, 2017, Oncogene.